Bonesupport Holding

BONEX · Nasdaq Stockholm · SEK

kr 227.00Change from previous close: +1.98%Absolute change: +kr 4.40

Close · October 5, 2026

Company profile

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Company facts

Industry
Medical Instruments & Supplies
Country
Sweden
Headquarters
Scheelevägen 19, 223 70, Lund
Employees
171
Listing
BONEX · Nasdaq Stockholm
Currency
SEK
ISIN
SE0009858152